Atlas Trials

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity

Clinical trial NCT05132088 · COMPLETED

Trial details

NCT number
NCT05132088
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Overweight and Obesity
Start date
2021-11-16
Primary completion
2023-07-11
Enrollment
201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.